These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30265414)

  • 1. Pharmacy-based management of influenza: lessons learned from research.
    Klepser ME; Adams AJ
    Int J Pharm Pract; 2018 Dec; 26(6):573-578. PubMed ID: 30265414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Views and experiences of community pharmacy team members on antimicrobial stewardship activities in Scotland: a qualitative study.
    Tonna AP; Weidmann AE; Sneddon J; Stewart D
    Int J Clin Pharm; 2020 Oct; 42(5):1261-1269. PubMed ID: 32803554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
    Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
    J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of rapid diagnostic tests for influenza: considerations for the community pharmacist.
    Koski RR; Klepser ME
    J Am Pharm Assoc (2003); 2017; 57(1):13-19. PubMed ID: 27836481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
    van Eikenhorst L; Salema NE; Anderson C
    Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of pharmacy practice research - Perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA.
    Babar ZU; Scahill S; Nagaria RA; Curley LE
    Res Social Adm Pharm; 2018 Dec; 14(12):1163-1171. PubMed ID: 29358030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community pharmacy interventions to improve antibiotic stewardship and implications for pharmacy education: A narrative overview.
    Bishop C; Yacoob Z; Knobloch MJ; Safdar N
    Res Social Adm Pharm; 2019 Jun; 15(6):627-631. PubMed ID: 30279131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient-centered pharmacy services model of HIV patient care in community pharmacy settings: a theoretical and empirical framework.
    Kibicho J; Owczarzak J
    AIDS Patient Care STDS; 2012 Jan; 26(1):20-8. PubMed ID: 22149903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A needs assessment of community pharmacists for pharmacist specialization in Canada.
    Jorgenson D; Penm J; MacKinnon N; Smith J
    Int J Pharm Pract; 2017 Apr; 25(2):159-167. PubMed ID: 27488476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of a pharmacist-physician collaborative program to manage influenza-like illness.
    Klepser ME; Klepser DG; Dering-Anderson AM; Morse JA; Smith JK; Klepser SA
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):14-21. PubMed ID: 26802915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to best manage time interaction with patients? Community pharmacist workload and service provision analysis.
    Gregório J; Cavaco AM; Lapão LV
    Res Social Adm Pharm; 2017; 13(1):133-147. PubMed ID: 26997136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions and current practices of community pharmacists regarding antimicrobial stewardship in Tasmania.
    Rizvi T; Thompson A; Williams M; Zaidi STR
    Int J Clin Pharm; 2018 Oct; 40(5):1380-1387. PubMed ID: 30069668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0).
    ;
    J Am Pharm Assoc (2003); 2008; 48(3):341-53. PubMed ID: 18595820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring organizational flexibility in community pharmacy: Building the capacity to implement cognitive pharmaceutical services.
    Feletto E; Wilson LK; Roberts AS; Benrimoj SI
    Res Social Adm Pharm; 2011 Mar; 7(1):27-38. PubMed ID: 21397879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative Community Pharmacy Practice Models in North Carolina.
    Hemberg N; Huggins D; Michaels N; Moose J
    N C Med J; 2017; 78(3):198-201. PubMed ID: 28576962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.